Kalytera Therapeutics Terminates Extraction Facility Letter of Intent

Kalytera Therapeutics (TSXV: KLY) announced this morning that it is walking away from a letter of intent signed earlier this year to acquire a 51% stake in an Oregon-based hemp extractor. The issuer cited declining market conditions for CBD isolate as the main reason for the termination of the letter of intent. The deal to […]

DioneyMed Brands CEO, Interim COO, Quit

DionyMed Brands (CSE: DYME) announced this morning that its Chief Executive Officer, as well as the firms interim Chief Operating officer have resigned effective immediately. Both individuals have resigned from all roles within the company, including its subsidiaries. The news of CEO Edward Fields and interim COO Mark Zinselmeier departing the company was issued as […]

Namaste Technologies Chief Strategy Officer Resigns

Namaste Technologies (TSXV: N) announced this morning that their Chief Strategy Officer, Darren Gill, has resigned from his position. Namaste indicated that the resignation is a result of Gill pursuing other opportunities. Gill was originally appointed to the role of Chief Strategy Officer back in February, at the same time Meni Morim was appointed as […]

Hexo Corp Targets Black Market with $4.49 Per Gram Product

Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced this morning their plan to target the black market on a price per gram basis, starting a long anticipated pricing war within the cannabis space. The firm announced this morning that it will begin selling 28 gram, or 1 oz equivalent, packs of cannabis at $125.70, a figure […]

WeedMD Receives Health Canada Amendment For Processing Facility

WeedMD Inc (TSXV: WMD) announced this morning that the firm has received a license amendment from Health Canada. The amendment relates to a processing facility that is located at its Strathroy, Ontario intended to process the firms outdoor-grown cannabis. The facility itself is a 50,000 square foot structure that has been custom built for the […]

The Reality of Aphria’s 2020 $1 Billion Canadian Cannabis Sales Run Rate Guidance

This morning, Aphria Inc (TSX: APHA) (NYSE: APHA) reaffirmed on its conference call that the firm is expecting a run rate of $1 billion in Canadian cannabis revenue by the fourth quarter of calendar year 2020. The firm had previously provided such guidance, and elected to reaffirm it despite recent guidance cancellations from other licensed […]

Indiva Sources Up To $11 Million In Financing

Indiva Limited (TSXV: NDVA) announced this morning that it has acquired financing of up to $11 million through an institutional lender. The funding comes in the form of a $6.5 million secured demand loan facility, and a $7.5 million secured bridge loan facility, with a cap being placed at a total of $11 million in […]

Emerald Health Disputes $7 Million Tab at Village Farms Joint Venture

Both Emerald Health Therapeutics (TSXV: EMH) and Village Farms International (TSX: VFF) (NASDAQ: VFF) announced this morning that their 50/50 joint venture firm, Pure Sunfarms, has entered into a dispute. The dispute, however, is with that of Emerald Health who doesn’t appear to want to abide by the terms of its supply agreement with the […]

Aphria Posts Revenues of $126.11 Million for First Quarter 2020

Aphria Inc (TSX: APHA) (NYSE: APHA) announced this morning revenues of $126.11 million, a decline from the previous quarters revenues of $128.56 million. Cannabis revenue increased to $30.78 million from $28.60 million in the prior quarter, while distribution revenue decline from $99.18 million to $95.32 million. The good news for Aphria investors, is that the […]